Loading
Latest filing published 24 Sept 2026 for Mantra Pharma Inc., €6,214. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Henry Park discloses dealings in 4 companies, chiefly Mantra 2 Real Estate Inc., Mantra Exploration Inc. and Mantra Pharma Inc. Altogether 11 filings, all relating to 24 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 24 September 2026, reports an option exercise of €6,214 in Mantra Pharma Inc. Half of the filings or more reach the SEDI feed on the day of the trade. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations